2021 Q3 Form 10-Q Financial Statement
#000119312521308672 Filed on October 27, 2021
Income Statement
| Concept | 2021 Q3 | 2020 Q4 |
|---|---|---|
| Revenue | $3.887B | $4.453B |
| YoY Change | -2.29% | 11.58% |
| Cost Of Revenue | $1.989B | $2.372B |
| YoY Change | -6.53% | 16.67% |
| Gross Profit | $1.898B | $2.081B |
| YoY Change | 2.59% | 6.28% |
| Gross Profit Margin | 48.83% | 46.73% |
| Selling, General & Admin | $864.0M | $965.0M |
| YoY Change | 1.29% | -2.62% |
| % of Gross Profit | 45.52% | 46.37% |
| Research & Development | $222.0M | |
| YoY Change | -6.72% | |
| % of Gross Profit | 11.7% | |
| Depreciation & Amortization | $329.0M | $395.0M |
| YoY Change | -13.65% | -5.05% |
| % of Gross Profit | 17.33% | 18.98% |
| Operating Expenses | $1.092B | $1.299B |
| YoY Change | -2.06% | 4.0% |
| Operating Profit | $806.0M | $782.0M |
| YoY Change | 9.66% | 10.3% |
| Interest Expense | -$254.0M | -$171.0M |
| YoY Change | 22.12% | -18.57% |
| % of Operating Profit | -31.51% | -21.87% |
| Other Income/Expense, Net | $13.00M | -$97.00M |
| YoY Change | -85.71% | -521.74% |
| Pretax Income | $382.0M | $137.0M |
| YoY Change | -108.57% | -451.28% |
| Income Tax | $76.00M | -$21.00M |
| % Of Pretax Income | 19.9% | -15.33% |
| Net Earnings | $290.0M | $149.0M |
| YoY Change | -106.67% | 35.45% |
| Net Earnings / Revenue | 7.46% | 3.35% |
| Basic Earnings Per Share | $0.26 | |
| Diluted Earnings Per Share | $261.5K | $136.1K |
| COMMON SHARES | ||
| Basic Shares Outstanding | 1.103B | |
| Diluted Shares Outstanding | 1.109B |
Balance Sheet
| Concept | 2021 Q3 | 2020 Q4 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $2.045B | $2.177B |
| YoY Change | 11.93% | 10.23% |
| Cash & Equivalents | $2.045B | $2.177B |
| Short-Term Investments | ||
| Other Short-Term Assets | $1.896B | $1.844B |
| YoY Change | 32.4% | 32.57% |
| Inventory | $4.167B | $4.403B |
| Prepaid Expenses | ||
| Receivables | $4.046B | $4.581B |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $12.15B | $13.01B |
| YoY Change | -0.05% | -3.41% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $6.547B | $6.855B |
| YoY Change | -2.41% | -1.37% |
| Goodwill | $20.18B | $20.62B |
| YoY Change | -0.24% | -16.99% |
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $1.139B | $1.233B |
| YoY Change | -14.49% | 26.07% |
| Total Long-Term Assets | $35.70B | $37.64B |
| YoY Change | -5.0% | -14.48% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $12.15B | $13.01B |
| Total Long-Term Assets | $35.70B | $37.64B |
| Total Assets | $47.85B | $50.64B |
| YoY Change | -3.79% | -11.88% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $1.514B | $1.756B |
| YoY Change | -11.77% | 2.21% |
| Accrued Expenses | $2.590B | $2.581B |
| YoY Change | 10.87% | -3.69% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $323.0M | $514.0M |
| YoY Change | -48.89% | 0.0% |
| Long-Term Debt Due | $2.386B | $2.674B |
| YoY Change | 61.87% | 46.04% |
| Total Short-Term Liabilities | $11.83B | $13.16B |
| YoY Change | -2.3% | -3.73% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $21.04B | $22.73B |
| YoY Change | -10.54% | -7.45% |
| Other Long-Term Liabilities | $2.628B | $2.720B |
| YoY Change | -0.94% | -11.54% |
| Total Long-Term Liabilities | $23.67B | $25.45B |
| YoY Change | -9.57% | -7.91% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $11.83B | $13.16B |
| Total Long-Term Liabilities | $23.67B | $25.45B |
| Total Liabilities | $37.38B | $40.61B |
| YoY Change | -6.88% | -6.63% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $10.47B | $10.03B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $47.85B | $50.64B |
| YoY Change | -3.79% | -11.88% |
Cashflow Statement
| Concept | 2021 Q3 | 2020 Q4 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $290.0M | $149.0M |
| YoY Change | -106.67% | 35.45% |
| Depreciation, Depletion And Amortization | $329.0M | $395.0M |
| YoY Change | -13.65% | -5.05% |
| Cash From Operating Activities | $529.0M | $331.0M |
| YoY Change | 72.31% | -38.48% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$146.0M | -$176.0M |
| YoY Change | 2.1% | 47.9% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $434.0M | $317.0M |
| YoY Change | 44.67% | -42.26% |
| Cash From Investing Activities | $288.0M | $141.0M |
| YoY Change | 83.44% | -67.21% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -1.177B | -125.0M |
| YoY Change | 11.35% | -48.13% |
| NET CHANGE | ||
| Cash From Operating Activities | 529.0M | 331.0M |
| Cash From Investing Activities | 288.0M | 141.0M |
| Cash From Financing Activities | -1.177B | -125.0M |
| Net Change In Cash | -360.0M | 347.0M |
| YoY Change | -39.29% | -52.27% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $529.0M | $331.0M |
| Capital Expenditures | -$146.0M | -$176.0M |
| Free Cash Flow | $675.0M | $507.0M |
| YoY Change | 50.0% | -22.83% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020Q4 | us-gaap |
Debt Instrument Fair Value
DebtInstrumentFairValue
|
25891000000 | |
| dei |
Entity Registrant Name
EntityRegistrantName
|
TEVA PHARMACEUTICAL INDUSTRIES LTD | ||
| dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
00-0000000 | ||
| dei |
Entity Address Country
EntityAddressCountry
|
IL | ||
| CY2020Q4 | us-gaap |
Goodwill
Goodwill
|
20624000000 | |
| CY2021Q3 | us-gaap |
Goodwill
Goodwill
|
20179000000 | |
| CY2021Q3 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
26000000 | |
| CY2020Q3 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
56000000 | |
| us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
106000000 | ||
| us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
408000000 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-377000000 |
